Clinical implications of plasma homocysteine measurement in cardiovascular disease

Journal of Clinical Pathology

Volumn 51, Issue 3, 1998, Pages 183-188

  Still, R A ^a   McDowell, I F W ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; VITAMIN; BIOLOGICAL MARKER;

AMINO ACID BLOOD LEVEL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; HUMAN; HYPERHOMOCYSTEINEMIA; LABORATORY TEST; MEASUREMENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOPHILIA; ARTERIOSCLEROSIS; BLOOD; BLOOD SAMPLING; CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; BLOOD SPECIMEN COLLECTION; CHROMATOGRAPHY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HOMOCYSTEINE; HUMANS; RISK FACTORS; THROMBOPHILIA;

EID: 0031976530     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.51.3.183     Document Type: Review

References (27)

1. Boushey CJ, Shirley SAA, Beresford AA, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57.
2. Frosst P, Blom HJ, Milos P, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Gen 1995;10:111-13.
3. Wilcken DEL. MTHFR 677C-T mutation, folate intake, neural-tube defect, and risk of cardiovascular disease. Lancet 1997;350:603-4.
4. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. JAMA 1997;277:1775-81.
5. Bellamy MF, McDowell IFW. Putative mechanisms for vascular damage by homocysteine. J Inher Metab Dis 1996;20: 307-15.
6. Den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334:759-62.
7. Rees MM, Rodgers GM. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 1993;71:337-59.
8. Ueland PM. Homocysteine species as components of plasma redox thiol status. Clin Chem 1995;41:340-2.
9. Ueland PM, Refsum H, Stabler SP, et al. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-79.
10. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott 1Mx analyzer. Clin Chem 1995;41:991-4.
11. Israelsson B, Brattström LE, Hultberg BJ. Homocysteine and myocardial infarction. Atherosclerosis 1988;71:227-34.
12. Stabler SP, Lindenbaum J, Savage DG, et al. Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood 1993;81:3404-13.
13. Evrovski J, Callaghan M, Cole D. Determination of homocysteine by HPLC with pulsed integrated amperometry. Clin Chem 1995;41:757-9.
14. Refsum H, Fiskerstrand T, Guttormesen AB, et al. Assessment of homocysteine status. J Inher Metab Dis 1997;20:286-94.
15. Ubbink JB, Vermaak WJH, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 1991;565: 441-6.
16. Kuo K, Still R, Cale S, et al. Standardisation (external and internal) of HPLC assay for plasma homocysteine. Clin Chem 1997;43:1653-5.
17. Guttormsen AB, Schneede J, Fiskerstrand T, et al. Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy subjects. J Nutr 1994;124:1934-41.
18. Ubbink JB, Vermaak WJH, van der Merwe A, et al. The effect of blood sample ageing and food consumption on plasma total homocysteine levels. Clin Chim Acta 1992;207: 119-28.
19. Bostom AG, Roubenhoff R, Dellaripa P, et al. Validation of abbreviated oral methionine-loading test. Clin Chem 1995; 41:948-9.
20. Fiskerstrand T, Refsum H, Kvalheim G, et al. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993;39:263-71.
21. Møller J, Rasmussen K. Homocysteine in plasma: stabilization of blood samples with fluoride. Clin Chem 1995;41: 758-9.
22. Garg UC, Zheng ZJ, Folsom AR, et al. Short-term and long-term variability of plasma homocysteine measurement. Clin Chem 1997;43:141-5.
23. Dudman NPB, Guo XW, Crooks R, et al. Assay of plasma homocysteine: light sensitivity of the fluorescent 7-benzo-2-oxa-1, 3-diazole-4-sulfonic acid derivative, and use of appropriate calibrators. Clin Chem 1996;42:2028-32.
24. Rasmussen K, Møller J, Lyngbak M, et al. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 1996;42:630-6.
25. Lindgren A, Brattström L, Norrving B, et al. Plasma homocysteine in the acute and convalescent phase after stroke. Stroke 1995;26:795-800.
26. Harmon DL, Woodside JV, Yarnell JWG, et al. The common "thermolabile" variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. Quart J Med 1996;89:571-7.
27. Duell PB, Malinow MR. Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease. Curr Opin Lipidol 1997;8:28-34.